• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

VBIT-4的膜破坏作用对其作为广泛使用的电压依赖性阴离子通道寡聚化抑制剂的作用提出了挑战。

A Membrane-Disruptive Action of VBIT-4 Challenges Its Role as a Widely Used VDAC Oligomerization Inhibitor.

作者信息

Ravishankar Varun, Borges-Araujo Luis, Lafargue Elodie, Byrne Deborah, Buzhinsky Nicolas, Wolfe Mya, Bautista Nina, Beyene Bethel, Larimi Motahareh, Duneau Jean-Pierre, Sturgis James, Rajendran Megha, Bezrukov Sergey, Casuso Ignacio, Rostovtseva Tatiana K, Bergdoll Lucie

出版信息

bioRxiv. 2025 Jul 3:2025.06.30.661942. doi: 10.1101/2025.06.30.661942.

DOI:10.1101/2025.06.30.661942
PMID:40747417
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12312184/
Abstract

VDAC, the most abundant protein in the outer mitochondrial membrane, plays a central role in mitochondrial physiology. Its oligomerization has been contemplated to be involved in critical processes such as mtDNA release and apoptosis, yet the underlying molecular mechanisms remain poorly defined. VBIT-4, a small molecule widely used as a VDAC1 oligomerization inhibitor, has seen extensive applications over the past five years without proper mechanistic characterization. Using high-speed atomic force microscopy, we directly visualized VDAC1 oligomerization in planar lipid membranes and examined the effects of VBIT-4. Unexpectedly, VBIT-4 partitioned into lipid bilayers at micromolar concentrations and disrupted membrane structure even in the absence of VDAC1. Complementary approaches, including single-channel electrophysiology, microscale thermophoresis, and coarse-grained molecular dynamics, confirmed the membrane partitioning and destabilizing effects of VBIT-4. The compound also induced VDAC1-independent cytotoxicity in HeLa cells at concentrations above 10 microM. Our findings demonstrate that VBIT-4 disrupts membrane integrity by partitioning into lipids and inducing membrane defects rather than specifically inhibiting VDAC1 oligomerization, highlighting the need for caution when interpreting results and the importance of revisiting conclusions drawn from its prior use.

摘要

电压依赖性阴离子通道(VDAC)是线粒体外膜中含量最丰富的蛋白质,在线粒体生理学中起着核心作用。人们认为其寡聚化参与了线粒体DNA释放和细胞凋亡等关键过程,但其潜在的分子机制仍不清楚。VBIT-4是一种广泛用作VDAC1寡聚化抑制剂的小分子,在过去五年中得到了广泛应用,但没有进行适当的机制表征。我们使用高速原子力显微镜直接观察了平面脂质膜中VDAC1的寡聚化,并研究了VBIT-4的作用。出乎意料的是,VBIT-4在微摩尔浓度下会分配到脂质双层中,甚至在没有VDAC1的情况下也会破坏膜结构。包括单通道电生理学、微量热泳动和粗粒度分子动力学在内的补充方法证实了VBIT-4的膜分配和去稳定作用。该化合物在浓度高于10微摩尔时还会在HeLa细胞中诱导不依赖VDAC1的细胞毒性。我们的研究结果表明,VBIT-4通过分配到脂质中并诱导膜缺陷来破坏膜完整性,而不是特异性抑制VDAC1寡聚化,这突出了在解释结果时需要谨慎,以及重新审视此前使用该化合物得出的结论的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5580/12312184/c6406100ee50/nihpp-2025.06.30.661942v1-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5580/12312184/a63710344596/nihpp-2025.06.30.661942v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5580/12312184/04e4a9824a85/nihpp-2025.06.30.661942v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5580/12312184/691f65e309db/nihpp-2025.06.30.661942v1-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5580/12312184/ec10a7a35983/nihpp-2025.06.30.661942v1-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5580/12312184/6875491e77a1/nihpp-2025.06.30.661942v1-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5580/12312184/4bd1d37d9d36/nihpp-2025.06.30.661942v1-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5580/12312184/ade5ca20a388/nihpp-2025.06.30.661942v1-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5580/12312184/d5f518c8dcf8/nihpp-2025.06.30.661942v1-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5580/12312184/c6406100ee50/nihpp-2025.06.30.661942v1-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5580/12312184/a63710344596/nihpp-2025.06.30.661942v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5580/12312184/04e4a9824a85/nihpp-2025.06.30.661942v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5580/12312184/691f65e309db/nihpp-2025.06.30.661942v1-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5580/12312184/ec10a7a35983/nihpp-2025.06.30.661942v1-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5580/12312184/6875491e77a1/nihpp-2025.06.30.661942v1-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5580/12312184/4bd1d37d9d36/nihpp-2025.06.30.661942v1-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5580/12312184/ade5ca20a388/nihpp-2025.06.30.661942v1-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5580/12312184/d5f518c8dcf8/nihpp-2025.06.30.661942v1-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5580/12312184/c6406100ee50/nihpp-2025.06.30.661942v1-f0009.jpg

相似文献

1
A Membrane-Disruptive Action of VBIT-4 Challenges Its Role as a Widely Used VDAC Oligomerization Inhibitor.VBIT-4的膜破坏作用对其作为广泛使用的电压依赖性阴离子通道寡聚化抑制剂的作用提出了挑战。
bioRxiv. 2025 Jul 3:2025.06.30.661942. doi: 10.1101/2025.06.30.661942.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Membrane lipid composition modulates the organization of VDAC1, a mitochondrial gatekeeper.膜脂组成调节线粒体守门蛋白VDAC1的组织。
Commun Biol. 2025 Jun 17;8(1):936. doi: 10.1038/s42003-025-08311-5.
4
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
5
Liquiritigenin alleviates inflammation and mitochondrial dysfunction in acute pancreatitis via ERβ-VDAC1 signaling.甘草素通过雌激素受体β-电压依赖性阴离子通道1信号通路减轻急性胰腺炎中的炎症和线粒体功能障碍。
J Ethnopharmacol. 2025 Sep 3;354:120526. doi: 10.1016/j.jep.2025.120526.
6
Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.纤维素、改性纤维素和合成膜在终末期肾病患者血液透析中的比较。
Cochrane Database Syst Rev. 2001(3):CD003234. doi: 10.1002/14651858.CD003234.
7
Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men.降低男男性行为者中艾滋病毒性传播风险的行为干预措施。
Cochrane Database Syst Rev. 2008 Jul 16(3):CD001230. doi: 10.1002/14651858.CD001230.pub2.
8
Aspects of Genetic Diversity, Host Specificity and Public Health Significance of Single-Celled Intestinal Parasites Commonly Observed in Humans and Mostly Referred to as 'Non-Pathogenic'.人类常见且大多被称为“非致病性”的单细胞肠道寄生虫的遗传多样性、宿主特异性及公共卫生意义
APMIS. 2025 Sep;133(9):e70036. doi: 10.1111/apm.70036.
9
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
10
Does Augmenting Irradiated Autografts With Free Vascularized Fibula Graft in Patients With Bone Loss From a Malignant Tumor Achieve Union, Function, and Complication Rate Comparably to Patients Without Bone Loss and Augmentation When Reconstructing Intercalary Resections in the Lower Extremity?对于因恶性肿瘤导致骨缺损的患者,在重建下肢节段性切除时,采用带血管游离腓骨移植来增强照射后的自体骨移植,其骨愈合、功能及并发症发生率与无骨缺损且未进行增强的患者相比是否相当?
Clin Orthop Relat Res. 2025 Jun 26. doi: 10.1097/CORR.0000000000003599.

本文引用的文献

1
Membrane lipid composition modulates the organization of VDAC1, a mitochondrial gatekeeper.膜脂组成调节线粒体守门蛋白VDAC1的组织。
Commun Biol. 2025 Jun 17;8(1):936. doi: 10.1038/s42003-025-08311-5.
2
Annexin A5 controls VDAC1-dependent mitochondrial Ca homeostasis and determines cellular susceptibility to apoptosis.膜联蛋白A5控制依赖电压依赖性阴离子通道1的线粒体钙稳态,并决定细胞对凋亡的敏感性。
EMBO J. 2025 May 9. doi: 10.1038/s44318-025-00454-9.
3
VDAC1 Inhibition Mitigates Inflammatory Status and Oxidative Stress in Epileptic Mice Treated with the Ketogenic Diet.
电压依赖性阴离子通道1抑制减轻生酮饮食治疗的癫痫小鼠的炎症状态和氧化应激。
Neurochem Res. 2025 Mar 14;50(2):118. doi: 10.1007/s11064-025-04366-2.
4
Structure of human PINK1 at a mitochondrial TOM-VDAC array.人PINK1在线粒体TOM-VDAC阵列处的结构。
Science. 2025 Apr 18;388(6744):303-310. doi: 10.1126/science.adu6445. Epub 2025 Mar 13.
5
Hexokinase-I directly binds to a charged membrane-buried glutamate of mitochondrial VDAC1 and VDAC2.己糖激酶-I直接与线粒体电压依赖性阴离子通道蛋白1(VDAC1)和电压依赖性阴离子通道蛋白2(VDAC2)中一个带电荷的膜内谷氨酸结合。
Commun Biol. 2025 Feb 10;8(1):212. doi: 10.1038/s42003-025-07551-9.
6
Inhibition of VDAC1 oligomerization blocks cysteine deprivation-induced ferroptosis via mitochondrial ROS suppression.抑制 VDAC1 寡聚化通过抑制线粒体 ROS 抑制半胱氨酸剥夺诱导的铁死亡。
Cell Death Dis. 2024 Nov 9;15(11):811. doi: 10.1038/s41419-024-07216-1.
7
Sulindac prevents increased mitochondrial VDAC1 expression and cell surface mistargeting induced by pathological conditions in retinal cells.舒林酸可预防病理条件诱导的视网膜细胞中线粒体 VDAC1 表达增加和细胞膜错误定位。
Biochem Biophys Res Commun. 2024 Dec 20;739:150558. doi: 10.1016/j.bbrc.2024.150558. Epub 2024 Aug 15.
8
Protocol for the production and reconstitution of VDAC1 for functional assays.用于功能测定的 VDAC1 的生产和复性方案。
STAR Protoc. 2024 Sep 20;5(3):103240. doi: 10.1016/j.xpro.2024.103240. Epub 2024 Aug 9.
9
Effect of VBIT-4 on the functional activity of isolated mitochondria and cell viability.VBIT-4 对分离的线粒体功能活性和细胞活力的影响。
Biochim Biophys Acta Biomembr. 2024 Jun;1866(5):184329. doi: 10.1016/j.bbamem.2024.184329. Epub 2024 Apr 26.
10
Phospholipids are imported into mitochondria by VDAC, a dimeric beta barrel scramblase.磷脂通过 VDAC(一种二聚体β桶结构的翻转酶)被导入线粒体。
Nat Commun. 2023 Dec 8;14(1):8115. doi: 10.1038/s41467-023-43570-y.